Approval · Notice of Compliance 8363 · 2006
FLUCONAZOLE: Notice of Compliance 8363
Issued October 27, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8363
- Date
- October 27, 2006
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- Antifungal agent
- Canadian reference product
- DIFLUCAN (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUCONAZOLE | 02287242 | — |
| FLUCONAZOLE | 02287250 | — |
| FLUCONAZOLE | 02287269 | — |
Medicinal ingredients
- FLUCONAZOLE 50 MG per TAB
- FLUCONAZOLE 100 MG per TAB
- FLUCONAZOLE 200 MG per TAB